Another drug recall due to cancer-causing ingredients
The FDA warned in late May and early June 2020 that some lots of extended-release metformin may contain unacceptable levels of N-nitrosodimethylamine (NDMA), a possible cancer-causing chemical.
Content restricted. Requires subscription